Advancing Diverse Representation in Clinical Trials and Research

HealthVerity offerings support the call for action by the Committee on Improving Representation of Women and Underrepresented Minorities in Clinical Trials and Research.

Celebrating Clinical Trials Day 2022

HealthVerity is pleased to celebrate Clinical Trials Day and all of the employees, volunteers, and patients who make clinical trials possible.

Clinical trials have come a long way since the first randomized trial aboard the HMS Salisbury of Britain’s Royal Navy fleet in 1747. The industry’s dedication to clinical trials helps lead to the discovery of new cures, improvements in public health and the saving of patient lives.

We are proud to support clinical trial innovation through the HealthVerity IPGE platform, an integrated technology and real-world data infrastructure based on the foundational elements of Identity, Privacy, Governance and Exchange. Our expertise in patient identity resolution, privacy-protection, consent governance and data exchange, including the nation’s largest interoperable healthcare and consumer data ecosystem, contributes directly to the success of these key clinical trial initiatives:

  • Increased Representation of Diverse Participants in Clinical Trials
    Our Provider Diversity Index (PDI) is the first of its kind syndicated report that provides insights into the racial mix of patients being served by individual U.S. physicians , all in a privacy-protected, HIPAA-compliant manner. This report is used to improve the recruitment of minority patients, per FDA guidance, and for work by insurance companies in redesigning physician networks to better address issues of inclusion, diversity and equity.
  • Real-World Data Insights on Populations Ineligible for Clinical Trials
    Our newly launched Maternal Outcomes Masterset (MOM) is a groundbreaking approach to generate novel insights around the impact of healthcare interventions for pregnant women and their babies. By accurately linking and householding de-identified healthcare records of over 1.6 million pregnant women to their newborns, HealthVerity delivers a more comprehensive way for clinical researchers to study the patient journey from pre-pregnancy to birth and beyond, all in a HIPAA-compliant and privacy-protected manner.
  • Improved Safety During Clinical Trials
    HealthVerity patient identity resolution technology enables researchers to better link a participant’s real-world data to patient data from investigators, which is ideal for contextualizing trial findings, learning from patients lost to follow-up and expanding coverage for safety surveillance.

At HealthVerity, we are grateful to pharmaceutical leaders and government agencies who have invested in these solutions for clinical trial innovation. Together, we are helping our communities by advancing breakthrough therapies to save and improve patient lives. Thank you to each and every one of you - including dedicated HealthVerity employees, customers, partners, and clinical trial patients!

Related Post:

Scaling a Hyper-Growth Tech Company

HealthVerity’s journey from an unknown startup to a major disrupter in the Healthcare industry

How RWE can support drug development during COVID-19 and beyond

The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical tri...

Longitudinal patient insights bridging clinical and real-word data

COVID-19 has heightened the need for an expanded understanding of clinical trial populations and patient insights both d...

Subscribe to the HealthVerity blog

Contact us